Evaluation and treatment of postmenopausal osteoporosis

C. Y. Wang, J. M. Bruder, C. D. Rubin

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Osteoporosis is a prevalent condition among elderly women and is associated with an increased risk for fractures. With the burgeoning size of the elderly population, a practitioner is likely to face many questions regarding the evaluation and management of postmenopausal osteoporosis. This review discusses and compares available therapies. All women should have adequate calcium and vitamin D intake. Women diagnosed as having osteoporosis should be evaluated for secondary causes of osteoporosis and risk factors for falls. For women with postmenopausal osteoporosis, therapy with hormone replacement, bisphosphonates (alendronate sodium or risedronate sodium), raloxifene hydrochloride, or calcitonin should be considered. The results of ongoing studies will help refine the strategies used for management of postmenopausal osteoporosis.

Original languageEnglish (US)
Pages (from-to)SP5-SP16
JournalAmerican Journal of Managed Care
Issue numberSPEC. ISS.
StatePublished - Nov 20 2001

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Evaluation and treatment of postmenopausal osteoporosis'. Together they form a unique fingerprint.

Cite this